Questions discussed in this category
Patient is already on topical high potency corticosteroids.
Any updated safety data on IL-17, IL-23 in pregnancy?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Bissonnette et al., PMID 38324484
For example, in patients with many swollen/tender joints, enthesitis, nail involvement do you expect particularly good response? Are there patients in...
In what cases do you discontinue the medication?
Are there ways to overcome barriers in insurance coverage of this combination of treatments?
2265922372218571389216101146649010
Papers discussed in this category
Journal of psoriasis and psoriatic arthritis, 2019-04
Front Pharmacol, 2019 Mar 26
The Journal of rheumatology, 2012-01
JAAD Case Rep, 2019 Oct 10
Current rheumatology reviews, 2019
Am J Clin Dermatol, 2022 Jun 23
The New England journal of medicine, 2024 Feb 08